ERBB2 and breast carcinoma: Moreover, some investigators suggest that breast cancer occurs mainly through two mechanisms: one is the amplification of HER2 or overexpression of the receptor tyrosine kinase (RTK) activation pathway; the second is that PI3K/AKT/mTOR pathway proteins undergo specific mutations [9,10].